| 000 | 01505 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515015101.0 | ||
| 264 | 0 | _c20060811 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0006-3223 | ||
| 024 | 7 |
_a10.1016/j.biopsych.2005.11.024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWichers, Marieke C | |
| 245 | 0 | 0 |
_aBaseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment. _h[electronic resource] |
| 260 |
_bBiological psychiatry _cJul 2006 |
||
| 300 |
_a77-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 |
_aDepressive Disorder, Major _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 |
_aInterleukin-10 _ximmunology |
| 650 | 0 | 4 |
_aInterleukin-6 _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Interleukin-2 _ximmunology |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aKenis, Gunter | |
| 700 | 1 | _aLeue, Carsten | |
| 700 | 1 | _aKoek, Ger | |
| 700 | 1 | _aRobaeys, Geert | |
| 700 | 1 | _aMaes, Michael | |
| 773 | 0 |
_tBiological psychiatry _gvol. 60 _gno. 1 _gp. 77-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopsych.2005.11.024 _zAvailable from publisher's website |
| 999 |
_c16099401 _d16099401 |
||